InvestorsHub Logo
Followers 89
Posts 12639
Boards Moderated 5
Alias Born 10/10/2017

Re: None

Friday, 11/22/2019 11:00:36 AM

Friday, November 22, 2019 11:00:36 AM

Post# of 32775
Here is a good read, from Feb. 2019 - follow the link below to read the whole article. But it clearly states

In accordance with our current business plan, the testing, research and development of both a medical device solution as well as a synthetic drug solution are underway, and we have contracted with certain third-party companies to research, develop, and test certain products that could be used to treat dementia utilizing Omentum. We have also contracted with various individuals to facilitate the introduction of the company to medical device testing organizations in overseas locations including Poland, China and Uzbekistan for the purpose of testing our medicinal treatments utilizing Omentum. Our management anticipates that we may form subsidiaries and joint ventures to develop different drugs based on the intellectual property.



https://www.marketwatch.com/press-release/10-q-cerebain-biotech-corp-2019-02-19
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.